Position in GH
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$547,569
New position
Shares Held
5,928
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026J. Safra Sarasin Holding AG holds $98,829,762 across 8 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
174,160 | $33,173,995 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
61,179 | $30,672,703 | |
| 3 | A |
Agilent Technologies, Inc.
|
229,477 | $30,481,426 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
4,666 | $2,456,367 | |
| 5 | NTRA |
Natera, Inc.
|
5,951 | $1,615,398 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,349 | $260,653 | |
| 7 | PSNL |
Personalis, Inc.
|
10,047 | $134,629 | |
| 8 | BIAF |
bioAffinity Technologies, Inc.
|
42,600 | $34,591 |
All Filings in GH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $547,569 | 5,928 | Shares | Defined | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||